Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.52B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
ProShares UltraPro QQQ
TQQQ
|
+$555M |
| 4 |
Dell
DELL
|
+$542M |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.18B |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.29B |
| 3 |
Visa
V
|
+$1.12B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$918M |
| 5 |
Broadcom
AVGO
|
+$892M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.93% |
| 2 | Consumer Discretionary | 1.52% |
| 3 | Healthcare | 0.84% |
| 4 | Financials | 0.83% |
| 5 | Communication Services | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRDN
9201
Meridian Holdings Inc
MRDN
$182M
| $26.3K | ﹤0.01% |
940
-620
| -40% | -$17.8K |
|
9202
Gold Royalty Corp
GROY
$699M
| $26.2K | ﹤0.01% |
19,269
-50,413
| -72% | -$68.5K |
|
9203
Rallybio
RLYB
$85.8M
| $26.1K | ﹤0.01% |
2,784
-3,851
| -58% | -$37.1K |
|
9204
Fractyl Health
GUTS
$111M
| $25.4K | ﹤0.01% |
+10,052
| New | +$32.8K |
|
9205
Heritage Global
HGBL
$36.8M
| $25.4K | ﹤0.01% |
+14,941
| New | +$30.6K |
|
9206
Codere Online Luxembourg Warrants
CDROW
$5.28M
| $25.2K | ﹤0.01% |
25,102
| – | – |
|
|
NIOBW
9207
NioCorp Developments Ltd Warrant
NIOBW
$79.3M
| $25.1K | ﹤0.01% |
201,049
| – | – |
|
|
BNKK
9208
Bonk Inc
BNKK
$8.4M
| $25.1K | ﹤0.01% |
587
-846
| -59% | -$29.6K |
|
|
ZOM
9209
DELISTED
Zomedica Corp.
ZOM
| $24.6K | ﹤0.01% |
+179,074
| New | +$25.1K |
|
9210
PUT
Tilray
TLRY
$622M
| $24.5K | ﹤0.01% |
1,390
-550
| -28% | -$9.9K |
|
|
AIFA
9211
All In FutureTech Alliance Inc
AIFA
$12.8M
| $24K | ﹤0.01% |
+2,924
| New | +$23.6K |
|
|
NEWP
9212
New Pacific Metals
NEWP
$1.17B
| $23.7K | ﹤0.01% |
+15,930
| New | +$23.1K |
|
|
AIFU
9213
AIFU Inc
AIFU
$221M
| $23.5K | ﹤0.01% |
+41
| New | +$23K |
|
9214
Zevia
ZVIA
$111M
| $23.5K | ﹤0.01% |
21,790
-97,281
| -82% | -$92.1K |
|
|
KYNB
9215
Kyntra Bio
KYNB
$29.4M
| $23.3K | ﹤0.01% |
2,337
-15,661
| -87% | -$236K |
|
|
MAXN
9216
CALL
DELISTED
Maxeon Solar Technologies
MAXN
| $23.3K | ﹤0.01% |
2,407
-16,798
| -87% | -$269K |
|
9217
TransCode Therapeutics
RNAZ
$4.19M
| $22.7K | ﹤0.01% |
+43
| New | +$17.4K |
|
9218
Virax Biolabs
VRAX
$2.38M
| $22.6K | ﹤0.01% |
+465
| New | +$26.7K |
|
|
SY
9219
So-Young International
SY
$219M
| $22.6K | ﹤0.01% |
+24,007
| New | +$21.5K |
|
|
QVCGA
9220
CALL
DELISTED
QVC Group Inc Series A
QVCGA
| $22.1K | ﹤0.01% |
726
-414
| -36% | -$13.1K |
|
9221
American Resources Corp
AREC
$293M
| $21.6K | ﹤0.01% |
23,739
-5,108
| -18% | -$3.08K |
|
9222
Prelude Therapeutics
PRLD
$390M
| $21.4K | ﹤0.01% |
10,361
-2,587
| -20% | -$12K |
|
|
SBDS
9223
DELISTED
Solo Brands Inc
SBDS
| $21.3K | ﹤0.01% |
377
-357
| -49% | -$25.4K |
|
|
THM
9224
International Tower Hill Mines
THM
$604M
| $21.2K | ﹤0.01% |
+37,858
| New | +$18.8K |
|
|
TELL
9225
PUT
DELISTED
Tellurian Inc.
TELL
| $20.9K | ﹤0.01% |
21,600
-31,400
| -59% | -$27.1K |
|
Similar funds
Jane Street's Q3 2024 Portfolio in Review
As of Q3 2024, Jane Street held 10,828 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Jane Street withdrew a net $18.5B in Q3 2024, closing 1,349 positions and reducing 4,327 holdings. Its most notable exit was iShares Core MSCI International Developed Markets ETF, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.9% of assets, down from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jane Street opened a new position in Schwab Short-Term US Treasury ETF worth $424M.
- Jane Street's largest Q3 2024 buy was Schwab Short-Term US Treasury ETF: 17,304,274 shares worth $424M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.52B increase.
- Jane Street's biggest Q3 2024 reduction was Apple, cutting an estimated $4.18B.
- Jane Street fully exited iShares Core MSCI International Developed Markets ETF in Q3 2024, selling an estimated $290M.
- Jane Street's ten largest holdings make up 44% of its $453B portfolio in Q3 2024.
- Jane Street opened 1,593 new positions and closed 1,349 in Q3 2024.
- Jane Street's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.